Copyright
©The Author(s) 2020.
World J Clin Cases. Nov 26, 2020; 8(22): 5603-5610
Published online Nov 26, 2020. doi: 10.12998/wjcc.v8.i22.5603
Published online Nov 26, 2020. doi: 10.12998/wjcc.v8.i22.5603
Figure 1 Blast cells in bone marrow at diagnosis.
Figure 2 CLAG-M protocol.
Ara-C: Cytarabine; BM: Bone marrow; G-CSF: Granulocyte colony-stimulating factor; MIT: Mitoxantrone.
Figure 3 Conditioning protocol for umbilical cord blood stem cell transplantation.
Ara-C: Cytarabine 1.5 g/m2 intravenously (q12 h, day -10 to day -9); Bu: Busulfan 0.8 mg/kg (q6 h × 12, day -9 to day -7); CTX: Cyclophosphamide 50 mg/kg intravenously (qd × 4 d); Flu: Fludarabine 30 mg/m2 (qd × 6 d).
- Citation: Huang J, Yang XY, Rong LC, Xue Y, Zhu J, Fang YJ. CLAG-M chemotherapy followed by umbilical cord blood stem cell transplantation for primary refractory acute myeloid leukaemia in a child: A case report. World J Clin Cases 2020; 8(22): 5603-5610
- URL: https://www.wjgnet.com/2307-8960/full/v8/i22/5603.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i22.5603